Serelaxin as a potential treatment for renal dysfunction in cirrhosis: Preclinical evaluation and results of a randomized phase 2 trial

• Victoria K. Snowdon ,

  Contributed equally to this work with: Victoria K. Snowdon, Neil J. Lachlan

  Affiliation MRC Centre for Inflammation Research, University of Edinburgh, Edinburgh, United Kingdom

  ⨯
• Neil J. Lachlan ,

  Contributed equally to this work with: Victoria K. Snowdon, Neil J. Lachlan

  Affiliation MRC Centre for Inflammation Research, University of Edinburgh, Edinburgh, United Kingdom

  ⨯
• Anna M. Hoy,

  Affiliation MRC Centre for Inflammation Research, University of Edinburgh, Edinburgh, United Kingdom

  ⨯
• Patrick W. F. Hadoke,

  Affiliation British Heart Foundation/University of Edinburgh Centre for Cardiovascular Science, University of Edinburgh, Edinburgh, United Kingdom

  http://orcid.org/0000-0002-1041-1781

  ⨯
• Scott I. Semple,

  Affiliations British Heart Foundation/University of Edinburgh Centre for Cardiovascular Science, University of Edinburgh, Edinburgh, United Kingdom, Clinical Research Imaging Centre, University of Edinburgh, Edinburgh, United Kingdom

  ⨯
• Dilip Patel,

  Affiliation Department of Radiology, Royal Infirmary of Edinburgh, Edinburgh, United Kingdom

  http://orcid.org/0000-0003-4892-0386

  ⨯
• Will Mungall,

  Affiliation Biological Services, University of Edinburgh, Edinburgh, United Kingdom

  ⨯
• Timothy J. Kendall,

  Affiliation MRC Centre for Inflammation Research, University of Edinburgh, Edinburgh, United Kingdom

  http://orcid.org/0000-0002-4174-2786

  ⨯
• Adrian Thomson,

  Affiliation British Heart Foundation/University of Edinburgh Centre for Cardiovascular Science, University of Edinburgh, Edinburgh, United Kingdom

  http://orcid.org/0000-0001-7320-300X

  ⨯
• Ross J. Lennen,

  Affiliation British Heart Foundation/University of Edinburgh Centre for Cardiovascular Science, University of Edinburgh, Edinburgh, United Kingdom

  ⨯
• Maurits A. Jansen,

  Affiliation British Heart Foundation/University of Edinburgh Centre for Cardiovascular Science, University of Edinburgh, Edinburgh, United Kingdom

  http://orcid.org/0000-0002-7077-0188

  ⨯
• Carmel M. Moran,

  Affiliation British Heart Foundation/University of Edinburgh Centre for Cardiovascular Science, University of Edinburgh, Edinburgh, United Kingdom

  ⨯
• Antonella Pellicoro,

  Affiliation MRC Centre for Inflammation Research, University of Edinburgh, Edinburgh, United Kingdom

  ⨯
• Prakash Ramachandran,

  Affiliation MRC Centre for Inflammation Research, University of Edinburgh, Edinburgh, United Kingdom

  http://orcid.org/0000-0001-5996-2413

  ⨯
• Isaac Shaw,

  Affiliation MRC Centre for Inflammation Research, University of Edinburgh, Edinburgh, United Kingdom

  http://orcid.org/0000-0002-5628-0318

  ⨯
• Rebecca L. Aucott,

  Affiliation MRC Centre for Inflammation Research, University of Edinburgh, Edinburgh, United Kingdom

  ⨯
• Thomas Severin,

  Affiliation Novartis Pharma, Basel, Switzerland

  ⨯
• Rajnish Saini,

  Affiliation Novartis Pharmaceuticals Corporation, East Hanover, New Jersey, United States of America

  ⨯
• Judy Pak,

  Affiliation Novartis Pharmaceuticals Corporation, East Hanover, New Jersey, United States of America

  http://orcid.org/0000-0001-9653-950X

  ⨯
• Denise Yates,

  Affiliation Novartis Institutes for BioMedical Research, Cambridge, Massachusetts, United States of America

  ⨯
• Neelesh Dongre,

  Affiliation Novartis Pharma, Basel, Switzerland

  ⨯
• Jeremy S. Duffield,

  Affiliation Division of Nephrology and Lung Biology, University of Washington, Seattle, Washington, United States of America

  ⨯
• David J. Webb,

  Affiliation British Heart Foundation/University of Edinburgh Centre for Cardiovascular Science, University of Edinburgh, Edinburgh, United Kingdom

  ⨯
• John P. Iredale,

  Affiliation MRC Centre for Inflammation Research, University of Edinburgh, Edinburgh, United Kingdom

  ⨯
• Peter C. Hayes,

  Affiliation MRC Centre for Inflammation Research, University of Edinburgh, Edinburgh, United Kingdom

  ⨯
•  [ ... ],
• Jonathan A. Fallowfield

  * E-mail: Jonathan.Fallowfield@ed.ac.uk

  Affiliation MRC Centre for Inflammation Research, University of Edinburgh, Edinburgh, United Kingdom

  http://orcid.org/0000-0002-5741-1471

  ⨯
• [ view all ]
• [ view less ]